These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Healthcare utilization and costs in children with stable and uncontrolled epilepsy. Cramer JA, Wang ZJ, Chang E, Powers A, Copher R, Cherepanov D, Broder MS. Epilepsy Behav; 2014 Mar; 32():135-41. PubMed ID: 24561658 [Abstract] [Full Text] [Related]
3. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization. Manjunath R, Paradis PE, Parisé H, Lafeuille MH, Bowers B, Duh MS, Lefebvre P, Faught E. Neurology; 2012 Oct 30; 79(18):1908-16. PubMed ID: 23077014 [Abstract] [Full Text] [Related]
4. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Faught RE, Weiner JR, Guérin A, Cunnington MC, Duh MS. Epilepsia; 2009 Mar 30; 50(3):501-9. PubMed ID: 19183224 [Abstract] [Full Text] [Related]
7. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database. Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J. Clin Ther; 2009 Nov 30; 31(11):2653-64. PubMed ID: 20110008 [Abstract] [Full Text] [Related]
11. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany. Strzelczyk A, Haag A, Reese JP, Nickolay T, Oertel WH, Dodel R, Knake S, Rosenow F, Hamer HM. Epilepsy Behav; 2013 Jun 30; 27(3):433-8. PubMed ID: 23591262 [Abstract] [Full Text] [Related]
13. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions. Bagalman E, Muser E, Choi JC, Durden E, Macfadden W, Haskins JT, Dirani R. Clin Ther; 2011 Oct 30; 33(10):1381-1390.e4. PubMed ID: 22000656 [Abstract] [Full Text] [Related]
15. A cost comparison of alternative regimens for treatment-refractory partial seizure disorder: an econometric analysis. Lee WC, Hoffmann MS, Arcona S, D'Souza J, Wang Q, Pashos CL. Clin Ther; 2005 Oct 30; 27(10):1629-38. PubMed ID: 16330300 [Abstract] [Full Text] [Related]
16. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L. Am J Geriatr Pharmacother; 2008 Aug 30; 6(3):138-46. PubMed ID: 18775388 [Abstract] [Full Text] [Related]